MedPath

Survey Study for Pain Management, Wound Care, Scar Care or UDT

Conditions
Wounds
Pain
Scars
Urinary Drug Testing
Registration Number
NCT02195063
Lead Sponsor
Rahm Foundation
Brief Summary

This is a survey study that will be given to patients who have been prescribed a topical compound for pain management, wound care or scar care or to patients who have been requested to do a urinary drug test (UDT) by their provider.

The initial survey for pain management, wound care, scar care or UDT will be given to the patient by their providers during their office visit.

Detailed Description

We have designed a survey study that will be given to patients who have been prescribed a topical compound for pain management, wound care or scar care or to patients who have been requested to do a urinary drug test (UDT) by their provider.

The initial survey for pain management, wound care, scar care or UDT will be given to the patient by their providers during their office visit.

Follow-up surveys will be given at 30, 60, and 90 days. These surveys will be collected by e-mail or follow-up calls from Datum Research, LLC, contract research organization.

Data collection for this study will be derived through the 4 patient surveys (initial, 30 day, 60 day, and 90 day) and the prescription written by the provider.

The survey study will enroll patients until December 31, 2014, or until sufficient numbers have been achieved.

Rahm Foundation will continue the study until:

* Sufficient information has accumulated to meet the scientific objectives of the Study (i.e. numeric targets or effect size)

* The feasibility of collecting sufficient information diminishes to unacceptable levels, poor enrollment, loss to follow-up and/or

* Other methods of gathering appropriate information become achievable or are deemed preferable.

Datum Research will need to have access to the prescription to see what compound was prescribed.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10000
Inclusion Criteria
  • Prescribed a topical cream for pain, scar care, or wound OR Provider preforms urinary drug test
Exclusion Criteria
  • Subjects with legally authorized representatives
  • Minors
  • Prisoners

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in pain survey results from baseline at 90 daysbaseline and 90 days

Survey on pain management

Change in scar care survey results from baseline at 30 daysbaseline and 30 days

Survey on scar care

Change in scar care survey results from baseline at 60 daysbaseline and 60 days

Survey on scar care

Change in pain survey results from baseline at 30 daysbaseline and 30 days

Survey on pain management

Change in pain survey results from baseline at 60 daysbaseline and 60 days

Survey on pain management

Change in scar care survey results from baseline at 90 daysbaseline and 90 days

Survey on scar care

Change in wound care survey results from baseline at 30 daysbaseline and 30 days

Survey on wound care

Change in wound care survey results from baseline at 60 daysbaseline and 60 days

Survey on wound care

Change in wound care survey results from baseline at 90 daysbaseline and 90 days

Survey on wound care

Change in UDT survey results from baseline at 30 daysbaseline and 30 days

Survey on urinary drug testing

Change in UDT survey results from baseline at 60 daysbaseline and 60 days

Survey on urinary drug testing

Change in UDT survey results from baseline at 90 daysbaseline and 90 days

Survey on urinary drug testing

Secondary Outcome Measures
NameTimeMethod
Change in pain survey results from 30 days at 60 days30 days and 60 days

Survey on pain management

Change in pain survey results from 30 days at 90 days30 days and 90 days

Survey on pain management

Change in pain survey results from 60 days at 90 days60 days and 90 days

Survey on pain management

Length of hospital stayat baseline

if applicable

Change in scar care survey results from 30 days at 60 days30 days and 60 days

Survey on scar care

Change in scar care survey results from 30 days at 90 days30 days and 90 days

Survey on scar care

Change in scar care survey results from 60 days at 90 days60 days and 90 days

Survey on scar care

Change in wound care survey results from 30 days at 60 days30 days and 60 days

Survey on wound care

Change in wound care survey results from 30 days at 90 days30 days and 90 days

Survey on wound care

Change in UDT survey results from 60 days at 90 days60 days and 90 days

Survey on urinary drug testing

Change in UDT survey results from 30 days at 60 days30 days and 60 days

Survey on urinary drug testing

Change in UDT survey results from 30 days at 90 days30 days and 90 days

Survey on urinary drug testing

Trial Locations

Locations (1)

Blueprint Pathways

🇺🇸

Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath